Dr. Bogdana Schmidt, MD

Dr. Schmidt practices at University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah.

Dr. Schmidt's NPI, 1386987865, was assigned on April 3, 2013. Dr. Schmidt graduated from UCSF School of Medicine in 2013. Dr. Schmidt's California license number on file is A133342.

Dr. Schmidt's primary practice is University of Utah Hospitals and Clinics - Unit, at 50 North Medical Drive, Salt Lake City, UT 84132 in Salt Lake County. The practice phone is (801) 581-2337.

Dr. Schmidt's primary practice is University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah. Dr. Schmidt is also affiliated with University of Utah Hospital. The medical group on file is University of Utah Health. Dmand AI also links Dr. Schmidt to 4 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schmidt practices, 6 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Schmidt's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Schmidt is board certified in urology by the American Board of Urology. Dmand AI has Dr. Schmidt's licenses on file in 6 states: California, Montana, Idaho, Utah, Wyoming and Nevada.

Dmand AI lists bladder removal, enlarged prostate transurethral surgery (TURP), kidney removal surgery, prostate cancer, prostate surgery, urinary endoscopy and urine flow blockage among the conditions Dr. Schmidt treats.

CMS data shows 347 Medicare services from Dr. Schmidt across 8 procedure codes in 2024, for 187 Medicare patients. Medicare paid $47,457 for them.

CMS counts 187 Medicare patients who saw Dr. Schmidt in 2024. The largest group is 65 to 74, with 97 patients. 70% of them have cancer, and 63% have high blood pressure. 7% are also on Medicaid. Their average risk score is 1.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Schmidt's median patient age at 72, with 21% women.

In 2024, Dr. Schmidt wrote 125 Medicare Part D claims for 47 patients. 77% of them were for generic drugs. CMS names the drug for 64 of them, across 4 drugs with 11 or more claims each, at $12,759 in total drug cost. In 2023, CMS named 48 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Schmidt for performance year 2024, reported as part of a group. Dr. Schmidt accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Schmidt as offering telehealth. CMS counts 11 procedures of prostate resection by Dr. Schmidt, more than 60% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 20 papers to Dr. Schmidt, published from 2015 to 2025. 2021 was the busiest year, with 4. The most frequent topics are Prostatic Neoplasms, Prostatectomy and Black People. Dr. Schmidt has published most often in Clin Genitourin Cancer. Dr. Schmidt's most frequent co-authors are John Thomas Leppert, MD, Christopher Burr Dechet, MD and Jay Shah, MD.

CMS Open Payments shows 76 general payments to Dr. Schmidt from 10 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 43% of the total. Ferring Pharmaceuticals Inc. paid the most, $18,645.

Dr. Schmidt graduated from UCSF School of Medicine in 2013.

Dr. Schmidt is in network with 18 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.